The Biotech Therapy for Atypical Patients by Clay Siegall

Dr, Clay Siegall is the founder, chairman, president and CEO of Seattle Genetics. Seattle Genetics was established in 1998 to address the unexplored medical field of antibody therapy for cancer and rare diseases. The company has grown regarding facilities, application, and staff capacity. Seattle Genetics was the first pioneer company to be approved by FDA […]

Read more The Biotech Therapy for Atypical Patients by Clay Siegall